Dupilumab-induced pityriasis rosea

JAAD Case Rep. 2023 Jan 6:33:27-29. doi: 10.1016/j.jdcr.2023.01.001. eCollection 2023 Mar.

Authors

Morgan Zabel¹, Grace A Hile², Alanna Shefler², Paul W Harms^{2

3}, May P Chan^{2

3}, Jennifer B Mancuso^{2

4}

Affiliations

¹ College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
² University of Michigan Department of Dermatology, Ann Arbor, Michigan.
³ Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
⁴ Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.

No abstract available

Keywords: IL, interleukin; cutaneous adverse reaction; dupilumab; medical dermatology; pityriasis rosea.

Publication types

Case Reports